ListedMainboardGLS
Glenmark Life Sciences Limited
Glenmark Life Sciences Limited is a mainboard IPO raising ₹1,513 Cr at ₹695 – ₹720 a share. It listed on 6 Aug 2021 and trades at ₹1,107 today, +53.7% against its issue price of ₹720. It was subscribed 44× in total.
₹720
Issue price
₹1,107
Price now
+53.7%
Since issue price
6 Aug 2021
Listed on
44×Subscribed (final) · all exchanges
44.2 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 42,42,379 | 15,68,29,300 | 37× |
| Foreign Institutional Investors | no separate quota | 6,96,92,760 | n/a |
| Domestic Financial Institutions | no separate quota | 5,99,14,740 | n/a |
| Mutual funds | no separate quota | 7,07,000 | n/a |
| Others | no separate quota | 2,65,14,800 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 32,32,770 | 39,61,29,640 | 123× |
| Corporates | no separate quota | 5,94,58,600 | n/a |
| Individuals | no separate quota | 30,96,58,060 | n/a |
| others | no separate quota | 2,70,12,980 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 75,43,130 | 11,03,65,220 | 15× |
| Cut Off | no separate quota | 8,54,88,100 | n/a |
| Price bids | no separate quota | 2,48,77,120 | n/a |
| Total | 1,50,18,279 | 66,33,24,160 | 44× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 07:24 pm IST.
How demand built
We hold no subscription readings for this issue.